Quick Answer
ALX ONCOLOGY HOLDINGS INC reported Shares Outstanding of 54.39 million shares for fiscal year 2025.
ALX ONCOLOGY HOLDINGS INC Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 54.39M | +2.5% |
| 2024 | 53.05M | +6.2% |
| 2023 | 49.95M | +22.2% |
| 2022 | 40.86M | +0.7% |
| 2021 | 40.59M | +1.9% |
| 2020 | 39.84M | +1158.1% |
| 2019 | 3.17M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 53.58M | +1.6% | +0.1% |
| June 30, 2025 | 53.51M | +2.0% | +0.2% |
| March 31, 2025 | 53.38M | +6.2% | +0.6% |
| December 31, 2024 | 53.05M | +6.2% | +0.6% |
| September 30, 2024 | 52.74M | +28.2% | +0.6% |
| June 30, 2024 | 52.45M | +28.0% | +4.3% |
| March 31, 2024 | 50.28M | +23.0% | +0.7% |
| December 31, 2023 | 49.95M | +22.2% | +21.4% |
- ALX ONCOLOGY HOLDINGS INC showed an increase of +2.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, ALX ONCOLOGY HOLDINGS INC’s shares outstanding has grown by 1617.4% (from 3.17 million shares to 54.39 million shares).
- The most recent figure is from ALX ONCOLOGY HOLDINGS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: